580 related articles for article (PubMed ID: 25635914)
21. [Physiological role of bacterial multidrug efflux pumps].
Nishino K
Yakugaku Zasshi; 2012; 132(1):45-50. PubMed ID: 22214579
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistance and efflux pumps: insights from molecular dynamics simulations.
Collu F; Cascella M
Curr Top Med Chem; 2013; 13(24):3165-83. PubMed ID: 24200357
[TBL] [Abstract][Full Text] [Related]
23. Multidrug efflux pumps in Staphylococcus aureus and their clinical implications.
Jang S
J Microbiol; 2016 Jan; 54(1):1-8. PubMed ID: 26727895
[TBL] [Abstract][Full Text] [Related]
24. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of efflux pumps in antimicrobial resistance, persistence, and community living of Vibrionaceae.
Kumar S; Lekshmi M; Stephen J; Ortiz-Alegria A; Ayitah M; Varela MF
Arch Microbiol; 2023 Nov; 206(1):7. PubMed ID: 38017151
[TBL] [Abstract][Full Text] [Related]
26. The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus.
Dymek A; Armada A; Handzlik J; Viveiros M; Spengler G; Molnar J; Kieć-Kononowicz K; Amaral L
In Vivo; 2012; 26(2):223-9. PubMed ID: 22351662
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of resistance of bacteria causing ventilator-associated pneumonia.
Szabo D; Silveira F; Fujitani S; Paterson DL
Clin Chest Med; 2005 Mar; 26(1):75-9. PubMed ID: 15802168
[TBL] [Abstract][Full Text] [Related]
28. Measuring the activity of active efflux in gram-negative bacteria.
Webber MA; Coldham NG
Methods Mol Biol; 2010; 642():173-80. PubMed ID: 20401594
[TBL] [Abstract][Full Text] [Related]
29. Multidrug efflux pumps of Gram-positive bacteria.
Schindler BD; Kaatz GW
Drug Resist Updat; 2016 Jul; 27():1-13. PubMed ID: 27449594
[TBL] [Abstract][Full Text] [Related]
30. Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395.
Smith KP; Kumar S; Varela MF
Arch Microbiol; 2009 Dec; 191(12):903-11. PubMed ID: 19876617
[TBL] [Abstract][Full Text] [Related]
31. Inducible Expression of a Resistance-Nodulation-Division-Type Efflux Pump in Staphylococcus aureus Provides Resistance to Linoleic and Arachidonic Acids.
Alnaseri H; Arsic B; Schneider JE; Kaiser JC; Scinocca ZC; Heinrichs DE; McGavin MJ
J Bacteriol; 2015 Jun; 197(11):1893-905. PubMed ID: 25802299
[TBL] [Abstract][Full Text] [Related]
32. The Major Facilitator Superfamily and Antimicrobial Resistance Efflux Pumps of the ESKAPEE Pathogen
Stephen J; Salam F; Lekshmi M; Kumar SH; Varela MF
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830254
[TBL] [Abstract][Full Text] [Related]
33. Membrane Efflux Pumps of Pathogenic
Stephen J; Lekshmi M; Ammini P; Kumar SH; Varela MF
Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208837
[TBL] [Abstract][Full Text] [Related]
34. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.
Sun J; Deng Z; Yan A
Biochem Biophys Res Commun; 2014 Oct; 453(2):254-67. PubMed ID: 24878531
[TBL] [Abstract][Full Text] [Related]
35. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
Fontaine F; Héquet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
Eur J Med Chem; 2015 May; 95():185-98. PubMed ID: 25817769
[TBL] [Abstract][Full Text] [Related]
36. An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.
Jamshidi S; Sutton JM; Rahman KM
Future Med Chem; 2016; 8(2):195-210. PubMed ID: 26824720
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Multidrug Efflux Pumps Belonging to the Major Facilitator Superfamily in Bacterial Pathogens.
Varela MF; Stephen J; Bharti D; Lekshmi M; Kumar S
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239119
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
[TBL] [Abstract][Full Text] [Related]
39. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
Misra R; Morrison KD; Cho HJ; Khuu T
J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
[TBL] [Abstract][Full Text] [Related]
40. Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps.
Wei P; Kaatz GW; Kerns RJ
Bioorg Med Chem Lett; 2004 Jun; 14(12):3093-7. PubMed ID: 15149651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
